18F-FDG-PET/CT引导调强放疗靶区定义改善头颈鳞癌区域控制与生存
中位随访31个月,多因素Cox回归显示FDG-PET/CT-based NTV较CT-based NTV显著改善CTVelective-nodal内控制、整体区域控制及总生存。
要点
- FDG-PET/CT-based NTV改善CTVelective-nodal内控制(HR 0.33,p=0.026)。
- FDG-PET/CT-based NTV改善整体区域控制(HR 0.62,p=0.027)与总生存(HR 0.71,p=0.033)。
- 原发灶同步局部复发时CTVelective-nodal复发风险显著增加(HR 12.4,p<0.001)。
核心结论
- FDG-PET/CT-based NTV较CT-based NTV显著改善CTVelective-nodal内控制、整体区域控制及总生存。
- 相当比例的CTVelective-nodal复发可能为原发灶同步局部复发所致的新发淋巴结表现。
研究设计与样本
- 46%的患者采用FDG-PET/CT-based NTV,中位随访31个月。
- 将显示区域复发的诊断影像与初始CT配准以重建确切复发部位,并行多因素Cox回归分析。
主要发现
- FDG-PET/CT-based NTV较CT-based NTV改善CTVelective-nodal内控制(HR 0.33,p=0.026)。
- FDG-PET/CT-based NTV改善整体区域控制(HR 0.62,p=0.027)。
- FDG-PET/CT-based NTV改善总生存(HR 0.71,p=0.033)。
- 原发灶同步局部复发时CTVelective-nodal复发风险增加(HR 12.4,p<0.001)。
关键数值与推荐
- FDG-PET/CT-based NTV较CT-based NTV改善CTVelective-nodal内控制(HR 0.33,p=0.026)。
- FDG-PET/CT-based NTV较CT-based NTV改善整体区域控制(HR 0.62,p=0.027)。
- FDG-PET/CT-based NTV较CT-based NTV改善总生存(HR 0.71,p=0.033)。
- 原发灶同步局部复发时CTVelective-nodal复发风险增加(HR 12.4,p<0.001)。
临床怎么用
- 结果支持靶区转化概念,提示FDG-PET有望指导头颈鳞癌择区颈部放疗的逐步剂量去 escalated。
- 对原发灶同步局部复发风险高的患者,需关注CTVelective-nodal复发风险增加。
局限性
- 本文为回顾性分析,FDG-PET/CT-based NTV仅用于46%的患者,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Multimodality imaging including 18F-FDG-PET has improved the detection threshold of nodal metastases in head and neck squamous cell carcinoma (HNSCC). The aim of this retrospective analysis is to investigate the impact of FDG-PET/CT-based nodal target volume definition (FDG-PET/CT-based NTV) on radiotherapy outcomes, compared to conventional CT-based nodal target volume definition (CT-based NTV). MATERIALS AND METHODS: Six-hundred-thirty-three patients treated for HNSCC with definitive (chemo)radiotherapy using IMRT/VMAT techniques between 2008 and 2017 were analyzed. FDG-PET/CT-based NTV was performed in 46% of the patients. The median follow-up was 31 months. Diagnostic imaging depicting the regional recurrence was co-registered with the initial CT-scan to reconstruct the exact site of the recurrence. Multivariate Cox regression analysis was performed to identify variables associated with radiotherapy outcome. RESULTS: FDG-PET/CT-based NTV improved control of disease in the CTVelective-nodal (HR: 0.33, p = 0.026), overall regional control (HR: 0.62, p = 0.027) and overall survival (HR: 0.71, p = 0.033) compared to CT-based NTV. The risk for recurrence in the CTVelective-nodal was increased in case of synchronous local recurrence of the primary tumor (HR: 12.4, p < 0.001). CONCLUSION: FDG-PET/CT-based NTV significantly improved control of disease in the CTVelective-nodal, overall regional control and overall survival compared to CT-based NTV. A significant proportion of CTVelective-nodal recurrences are potentially new nodal manifestations from a synchronous local recurrent primary tumor. These results support the concept of target volume transformation and give an indication of the potential of FDG-PET to guide gradual radiotherapy dose de-escalation in elective neck treatment in HNSCC.
引用
- van den Bosch S, Doornaert PAH, Dijkema T, et al. 18F-FDG-PET/CT-based treatment planning for definitive (chemo)radiotherapy in patients with head and neck squamous cell carcinoma improves regional control and survival. Radiother Oncol. 2019. PMID: 31439447. doi:10.1016/j.radonc.2019.07.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。